Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maralixibat Extension in Alagille Syndrome (IMAGINE-II)
NCT02117713Phase 2Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Mar 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of maralixibat in Alagille syndrome (ALGS), sponsored by Mirum Pharmaceuticals, Inc.. Started Mar 2015; status: completed.
02
Drugs
maralixibat
03
Conditions
Alagille syndrome (ALGS)
Beyond the preview
Go deeper on NCT02117713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117713.